Crossmark

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Crossref DOI link: https://doi.org/10.1136/rmdopen-2021-001660

Published Online: 2021-07-02

Published Print: 2021-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Kedor, Claudia https://orcid.org/0000-0001-9361-9213
Detert, Jacqueline

Rau, Rolf

Wassenberg, Siegfried

Listing, Joachim

Klaus, Pascal

Braun, Tanja

Hermann, Walter

Weiner, Stefan Markus

Buttgereit, Frank https://orcid.org/0000-0003-2534-550X
Burmester, Gerd R https://orcid.org/0000-0001-7518-1131
Clinical Trials ^BETA

Clinical trials referenced in this document:

isrctn46445413 at ISRCTN.org

Documents that mention this clinical trial

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
https://doi.org/10.1136/rmdopen-2021-001660
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung (01KG1106)
License Information

License valid from 2021-07-02

Document is current

Any future updates will be listed below